Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?

Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?

Drug-eluting stents (DES) showed improved efficacy and safety compared with bare-metal stents (BMS), and international guidelines recommend their use as first line treatment. Yet, BMS are still widely used in practice, especially in large coronary vessels. We aimed to compare efficacy and safety of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation. Cardiovascular interventions 2019-09, Vol.12 (9), p.e007705-e007705
Hauptverfasser: Costa, Francesco, Brugaletta, Salvatore, Pernigotti, Alberto, Flores-Ulmanzor, Eduardo, Ortega-Paz, Luis, Cequier, Angel, Iniguez, Andres, Serra, Antoni, Jiménez-Quevedo, Pilar, Mainar, Vicente, Campo, Gianluca, Tespili, Maurizio, den Heijer, Peter, Bethencourt, Armando, Vazquez, Nicolás, van Es, Gerrit Anne, Backx, Bianca, Valgimigli, Marco, Serruys, Patrick, Sabaté, Manel
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Drug-eluting stents (DES) showed improved efficacy and safety compared with bare-metal stents (BMS), and international guidelines recommend their use as first line treatment. Yet, BMS are still widely used in practice, especially in large coronary vessels. We aimed to compare efficacy and safety of second-generation DES over BMS in large coronary culprit ST-segment elevated myocardial infarction lesions. We evaluated impact of large coronary stents (maximum size ≥3.50 mm) or smaller stents (
ISSN:1941-7632
DOI:10.1161/CIRCINTERVENTIONS.118.007705